20.500.12556/DiRROS-27400 The role of antibody-drug conjugates in the treatment of lung cancer Over the last decades, lung cancer treatment has improved immensely, mainly due to the incorporation of new targeted treatments and immunotherapy. A relatively new and potentially highly effective class of drugs, antibody-drug conjugates (ADCs), has been introduced to the clinical setting and is currently under intense investigation, alone and in combination with other molecules. This study aims to summarize the latest data on ADCs for lung cancer treatment and to analyze their potential, toxicity profile, and challenges. ADC antibody-drug conjugate non-small cell lung cancer small-cell lung cancer targeted therapy immunotherapy konjugati protitelo-zdravilo nedrobnocelični pljučni rak drobnocelični pljučni rak tarčno zdravljenje imunoterapija true false true Frontiers Editorial Office, 2011- Frontiers in oncology Angleški jezik Slovenski jezik © 2026 Zlatanova, Changalova and Janzic. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Neznano 2026-02-05 12:09:18 2026-02-05 12:09:19 2026-02-06 03:51:18 0000-00-00 00:00:00 2026 0 0 Nasl. z nasl. zaslona; Vse avtorice so k temu delu prispevale enakovredno; Soavtorica iz Slovenije: Urška Janžič; Opis vira z dne 5. 2. 2026; 18 str. article no. ǂ1757564 Vol. 16 5 Feb. 2026 0000-00-00 Zaloznikova Objavljeno apc 2025-11-30 2026-01-22 2026-02-05 616.24-006:615.277 2234-943X 10.3389/fonc.2026.1757564 267418115 https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1757564/full 1 20a56a06-0283-11f1-93b0-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=40075 RAZ_Zlatanova_Tanya_2026.pdf RAZ_Zlatanova_Tanya_2026.pdf 1 89294717696C65E25AAE4B6C1018ED62 6a5c823ad1c10d8588da2dc036e655a247d113b3fdc0fa866110d5ee6ee05dd8 98f2997d-0283-11f1-93b0-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=40076 Univerzitetna klinika za pljučne bolezni in alergijo Golnik 0 0 0